SERVİER İLAÇ VE ARAŞTIRMA A.Ş.

Company Introduction for SERVİER İLAÇ VE ARAŞTIRMA A.Ş.

SERVİER İLAÇ VE ARAŞTIRMA A.Ş. is the Turkish subsidiary of Servier, a leading global independent pharmaceutical group headquartered in France. The company operates in Turkey to market, sell, and distribute Servier's innovative pharmaceutical products. Its portfolio typically spans a wide range of therapeutic areas, including cardiovascular diseases, diabetes, oncology, central nervous system disorders, and rheumatology. Beyond commercial activities, SERVİER İLAÇ VE ARAŞTIRMA A.Ş. also engages in local clinical research and development initiatives, contributing to healthcare advancements in Turkey. The company's mission is to provide high-quality medicines to patients and healthcare professionals, leveraging the global expertise and research capabilities of the Servier group.

Type of business: Pharmaceutical Company (Part of a Manufacturing Group)

SERVİER İLAÇ VE ARAŞTIRMA A.Ş. is the local representative and operational arm of a global pharmaceutical manufacturer. It is not solely a trader. While its core activities in Turkey include the marketing, sales, and distribution of products manufactured by its parent company, it is an integral part of a group that designs, develops, and produces pharmaceuticals. It also potentially conducts local packaging or secondary manufacturing processes, alongside its significant research and commercial operations. Therefore, it is best described as a pharmaceutical company that belongs to a manufacturing group.

Here are some products that Servier İlaç ve Araştırma A.Ş. in Turkey may produce or market:

* **Cardiology:** Covers medications for cardiovascular diseases.

* **Diabetes:** Includes treatments for diabetes.

* **Oncology:** Features drugs for cancer treatment.

* **Neuropsychiatry:** Contains medications for mental health conditions.

* **Venology:** Products related to venous diseases.